Morgan Stanley Upgrades Insmed (INSM) to Overweight

March 30, 2026 4:13 AM

Morgan Stanley analyst Maxwell Skor upgraded Insmed (NASDAQ: INSM) from Equalweight to Overweight with a price target of $212.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found